Quick Takeaways
- Stonepine Capital Management, LLC filed SCHEDULE 13G/A for Inovio Pharmaceuticals, Inc. Common Stock (INO).
- Disclosed ownership: 3.8%.
- Date of event: 31 Mar 2025.
Stonepine Capital Management, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Inovio Pharmaceuticals, Inc. Common Stock (INO)
- Filing Manager
- Stonepine Capital Management, LLC
- Reporting Manager
- Stonepine Capital Management, LLC
- Symbol
- INO
- Shares outstanding
- 37,763,079 shares
- Disclosed Ownership
- 1,434,997 shares
- Ownership
- 3.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 May 2025, 16:10:04 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 23 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Stonepine Capital Management, LLC disclosed 3.8% ownership in Inovio Pharmaceuticals, Inc. Common Stock (INO) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 23 Dec 2024.
- Current filing was accepted on 14 May 2025, 16:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 3.8% | 1,434,997 | 0 | 1,434,997 | /s/ Jon M Plexico | Managing Member | |
| Stonepine Capital, L.P. | 3.8% | 1,434,997 | 0 | 1,434,997 | /s/ Jon M. Plexico | Managing Member of the General Partner, Stonepine GP, LLC | |
| Stonepine GP, LLC | 3.8% | 1,434,997 | 0 | 1,434,997 | /s/ Jon M. Plexico | Managing Member | |
| Jon M. Plexico | 3.8% | 1,434,997 | 0 | 1,434,997 | /s/ Jon M. Plexico | Reporting person |